These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7181586)

  • 1. Enhanced plasma binding of propranolol and oxprenolol and induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the dog.
    Belpaire FM; Rosseel MT; De Rick A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):303-4. PubMed ID: 7181586
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced serum binding of propranolol and oxprenolol and microsomal enzyme induction by rifampicin in the dog.
    Belpaire FM; Rosseel MT; Bogaert MG; De Rick A; D'Heer F
    Biochem Pharmacol; 1983 Mar; 32(6):1122-5. PubMed ID: 6838658
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the assay of alpha 1-acid glycoprotein in dog serum and its application to the plasma binding of propranolol and oxprenolol in animals receiving rifampicin.
    Delcroix C; Fraeyman N; Belpaire F
    J Pharmacol Methods; 1984 Sep; 12(2):97-105. PubMed ID: 6536820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
    Zilly W; Wernze H; Buchenau D; Breimer DD; Richter E
    Verh Dtsch Ges Inn Med; 1975; 81():1677-80. PubMed ID: 1227056
    [No Abstract]   [Full Text] [Related]  

  • 7. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
    Abramson FP; Lutz MP
    Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: species differences and influence of endotoxin.
    Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
    Chirality; 1995; 7(8):616-22. PubMed ID: 8593255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
    Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
    J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
    Schneider RE; Bishop H; Kendall MJ; Quarterman CP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog.
    Abramson FP; Robinson D; Bai SA
    Biochem Pharmacol; 1983 Sep; 32(17):2618-20. PubMed ID: 6615557
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse.
    Powis G; Snow DH
    J Pharmacol Exp Ther; 1978 Jun; 205(3):725-31. PubMed ID: 660540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):219-27. PubMed ID: 1233266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
    Wood AJ; Kornhauser DM; Wilkinson GR; Shand DG; Branch RA
    Clin Pharmacokinet; 1978; 3(6):478-87. PubMed ID: 719984
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs.
    Groen K; Breimer DD
    Methods Enzymol; 1996; 272():169-77. PubMed ID: 8791775
    [No Abstract]   [Full Text] [Related]  

  • 20. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.